P10-12. Altered NK cell phenotype and function in Ugandans with chronic HIV-1 infection by Robb ML, Wabwire-Mangen F, de Souza MS, Michael NL, Marovich MA, Guwatudde D, Kijak GH, Koehler RN, Eller L, Eller MA, Currier JR, Sandberg JK

S011-05 OA. HLA-A*7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, Tanzania by McCutchan FE, Michael NL, Robb ML, Hoelscher M, Maboko L, Ratto-Kim S, Moqueet N, Bautista CT, Currier JR, Saathoff E, Walsh AM, Koehler RN, Kim JH, Kijak GH

Analysis of SARS-CoV-2 Emergent variants following AZD7442 (tixagevimab/cilgavimab) for early outpatient treatment of COVID-19 (TACKLE trial) by Kijak, GH, Ahani, B, Arbetter, D, Chuecos, F, Gopalakrishnan, V, Beloor, J, Brady, T, Nguyen, A, Roe, TL, Schuko, N, Zhang, T, Hobbs, FDR, Padilla, F, Kelly, EJ, Montgomery, H, Streicher, K

T-cell based sieve analysis ties HLA A*02 to vaccine efficacy and IgA-C1 immune correlate in RV144 Thai trial by Hertz T, Gartland A, Janes H, Li S, Fong Y, Tomaras GD, Morris D, Geraghty D, Kijak GH, Edlefsen PT, Rolland M, Larsen BB, Tovanabutra S, Sanders-Buell E, DeCamp AC, Magaret CA, Ahmed H, Nariya S, Wong K, Zhao H, Deng W, Maust BS, Bose M, Howell S, Lazzaro M, Bates A, Lei E, Bradfield A, Ibitamuno G, Assawadarachai V, O'Connel RJ, deSouza MS, Nitayaphan S, Rerks-Ngarm S, Robb ML, McElrath MJ, Haynes BF, Michael NL, Gilbert PB, Mullins JI, Kim JH